A. Tanuja, S. Ganapaty, Varanasi S N Murthy
A. Tanuja1*, S. Ganapaty2, Varanasi S N Murthy3
1,2Department of Pharmaceutical Analysis and Quality Assurance, GIP, GITAM (Deemed to be University), Rushikonda, Visakhapatnam - 530045, India.
3Scientist, FRD, Dr. Reddy’s Laboratories, IPDO, Bachupally, Hyderabad - 500090, India.
Volume - 14,
Issue - 7,
Year - 2021
The current work aims to establish a novel and advanced reverse phase isocratic liquid chromatography system followed by validation and to conduct stability analysis in active pharmaceutical ingredients and formulations for the quantification of Solifenacin Succinate. The optimized elution was achieved with column Sunfire C8 (4.6 x 150mm, 5µm), using the mobile phase of Buffer: Methanol: Acetonitrile in the composition ratio of 45:45:10 v/v. The wavelength of detection was selected as 220nm with 1.0ml/ min flow rate and 30µl injection volume. The retention time of Solifenacin Succinate was found 2.94 min respectively. The method developed has been validated for various analytical parameters according to ICH guidelines. The Linearity was attained at 20 to100 µg/ml of concentration range. The established method was proved as reproducible. The Assay was obtained as 100.40%. The degradation studies were carried out at all degradative conditions and the results of degradation studies denote that the current method was specific, reliable, and economical. Hence, the developed method can be applied for the qualitative and quantitative determination of the selected drug and its commercial formulations.
Cite this article:
A. Tanuja, S. Ganapaty, Varanasi S N Murthy. Stability Indicating RP-HPLC Method Development and Validation for the Determination of Solifenacin Succinate in Bulk and its Pharmaceutical Formulation. Research Journal of Pharmacy and Technology. 2021; 14(7):3509-4. doi: 10.52711/0974-360X.2021.00608
A. Tanuja, S. Ganapaty, Varanasi S N Murthy. Stability Indicating RP-HPLC Method Development and Validation for the Determination of Solifenacin Succinate in Bulk and its Pharmaceutical Formulation. Research Journal of Pharmacy and Technology. 2021; 14(7):3509-4. doi: 10.52711/0974-360X.2021.00608 Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-7-5
1. Bhavana V, Kumar HT, Rao SY, Rao VP. RP-HPLC Method for Estimation of Solifenacin Succinate in API and Tablet Dosage Form. Asian Journal of Pharmaceutical Analysis. 2019; 9(3): 118-22.
2. Chandra Mohan T, Hemalatha B, Shainy B, Vasundhara G, Sandhya S, Ashok Kumar A. A rapid RP-HPLC method development and validation for the quantitative estimation of solifenacin succinate in tablets. International Journal of Pharmacy and Pharmaceutical Sciences. 2014; 6: 201-4.
3. Ganthi HK, Reddy R, Park YJ, Bapatu HR, Park SJ, Cho WH. Stability indicating HPLC method for quantification of solifenacin succinate & tamsulosin hydrochloride along with its impurities in tablet dosage form. American Journal of Analytical Chemistry. 2016; 7(11): 840-62.
4. Reddy R, Sidhaye R, Sherikar AV, Nadre M, Krishna M. Development and Validation of A Stability Indicating Analytical Method For Determination of Related Substances by RPHPLC For Solifenacin Succinate in Solifenacin Succinate Tablets. Pharmacophore. 2017; 8(2): 142-149.
5. Rakesh B, Bhargavi P, Reddy SR, Kumar AA. UV-Spectrophotometric method development and validation for the quantitative estimation of solifenacin succinate in tablets. Int J Pharm Pharm Sci. 2014; 6:190-3.
6. Reddy BV, Reddy BS, Raman NV, Reddy KS, Rambabu C. Development and validation of a specific stability indicating high performance liquid chromatographic methods for related compounds and assay of solifenacin succinate. Journal of Chemistry. 2012.
7. Desai D, Patel G, Shukla N, Rajput S. Development and validation of stability-indicating HPLC method for solifenacin succinate: isolation and identification of major base degradation product. Acta Chromatographica. 2012; 24(3):399-418.
8. Krishna SR, Rao BM, Rao NS. A validated rapid stability-indicating method for the determination of related substances in solifenacin succinate by ultra-fast liquid chromatography. Journal of Chromatographic Science. 2010; 48(10): 807-10.
9. Desai N, Hussen SS, Vasanthraju SG, Karthik A, Udupa N. Development & validation of stability indicating HPLC method for determination of Solifenacin in bulk formulations. International Journal of Pharmacy and Pharmaceutical Sciences.2011; 3(1):70-4.
10. Singh L, Nanda S. Spectrophotometric estimation of solifenacin succinate in tablet formulations. Pharmaceutical methods. 2011; 2(1) :21-4.
11. Wein AJ. Pharmacological agents for the treatment of urinary incontinence due to overactive bladder. Expert Opinion on Investigational Drugs. 2001; 10(1): 65-83.
12. Ikeda K, Kobayashi S, Suzuki M, Miyata K, Takeuchi M, Yamada T, Honda K. M 3 receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland. Naunyn-Schmiedeberg's Archives of Pharmacology. 2002; 366(2): 97-103.
13. Michel MC, Oelke M, Zinner N. Novel muscarinic antagonists to treat incontinence and/or overactive bladder. Drug Discovery Today: Therapeutic Strategies. 2005; 2(1):1-6.
14. Munro G. ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients (APIs). ICH Quality Guidelines. 2018:509.
15. ICH I. Q2 (R1): Validation of analytical procedures: text and methodology. in International Conference on Harmonization, Geneva 2005 Nov.
16. Khan H, Ali M, Ahuja A, Ali J. Stability testing of pharmaceutical products-comparison of stability testing guidelines. Current Pharmaceutical Analysis. 2010; 6(2):142-50.
17. ICH, “Stability testing of new drugs substances and products (Q1AR),” in International Conference on Harmonization (IFPMA '00), Geneva, Switzerland, 2000.
18. Draft IC. Guidelines on Validation of Analytical Procedures Definitions and Terminology. Federal Register. 1995; 60:1126.
19. Shaik RP, Puttagunta SB, Kothapalli Bannoth C, Challa BS. Analytical method development and validation of solifenacin in pharmaceutical dosage forms by RP-HPLC. ISRN Analytical Chemistry. 2014; 1(2): 1-5.
20. Hassan AK. Adjusting and Resetting of the Pre-determined Storage Temperature for O/W Emulsions. Indian Journal of Pharmaceutical Sciences. 2019; 27(4): 699-708.